Recombinant Newcastle Disease Virus as a Vaccine Vector for Cancer Therapy

Naturally occurring strains of Newcastle disease virus (NDV) are currently being investigated in multiple clinical trials for oncolytic cancer therapy in the United States and abroad. We have previously reported, for the first time, the development of recombinant NDVs designed for enhanced cancer th...

Descripción completa

Detalles Bibliográficos
Autores principales: Vigil, Adam, Martinez, Osvaldo, Chua, Mark A, García-Sastre, Adolfo
Formato: Texto
Lenguaje:English
Publicado: The American Society of Gene Therapy. Published by Elsevier Inc. 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878970/
https://www.ncbi.nlm.nih.gov/pubmed/18714310
http://dx.doi.org/10.1038/mt.2008.181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878970/
https://www.ncbi.nlm.nih.gov/pubmed/18714310
http://dx.doi.org/10.1038/mt.2008.181

Ejemplares similares